Insiders · Profile

HALPERN JOHN D

10% owner at Ernexa Therapeutics. Filing since 2 Dec 2022. CIK 0001234950

Company
Date
Role
Action
Shares
Amount
Of holding
2 Dec 2022
10% owner
Bought
335,920
$1.10M
292%
1 decision on file.